IP Library Granted Patent US 8,022,234
Granted Patent B2
US 8,022,234 · App. 12/571,060 · Granted Sep 20, 2011

Compounds and compositions

Assignee: Harbor BioSciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,022,234
App. No.
12/571,060
Granted
Sep 20, 2011
Kind
B2
Abstract

The invention provides compositions comprising formula 1 steroids, e.g., 16α-bromo-3β-hydroxy-5α-androstan-17-one hemihydrate and one or more excipients, including compositions that comprise a liquid formulation comprising less than about 3% v/v water. The compositions are useful to make improved pharmaceutical formulations. The invention also provides methods of intermittent dosing of steroid compounds such as analogs of 16α-bromo-3β-hydroxy-5α-androstan-17-one and compositions useful in such dosing regimens. The invention further provides compositions and methods to inhibit pathogen replication, ameliorate symptoms associated with immune dysregulation and to modulate immune responses in a subject using the compounds. The invention also provides methods to make and use these immunomodulatory compositions and formulations.

Claims (28)

1. A pharmaceutical formulation comprising one or more excipients and a compound having the structure

wherein

R 1 and R 4 independently are —OH, an ester or an ether;

R 2 is —H, —OH, an ester or an ether

R 3 is —OH, an ester, an ether or halogen; and

R 8 is —O— or —CHR 10 — wherein R 10 is —OH.

2. The formulation of claim 1 wherein R 1 , R 2 and R 4 are —OH or an ester and R 3 is —OH, an ester or —Br.

3. The formulation of claim 2 wherein the compound has the structure

4. The formulation of claim 2 wherein the compound has the structure

5. The formulation of claim 3 wherein the compound has the structure

6. The formulation of claim 5 wherein R 1 , R 2 and R 4 are —OH and R 3 is —OH or —Br.

7. The formulation of claim 1 wherein the formulation is for oral administration.

8. The formulation of claim 6 wherein the formulation is for oral administration.

9. A compound having the structure

wherein

R 1 , R 2 and R 4 independently are —OH, an ester or an ether;

R 3 is —OH, an ester, an ether or halogen

R 5 is —CH 3 or —CH 2 OH; and

R 6 is —H, —CH 3 or —CH 2 OH.

10. The compound of claim 9 wherein R 1 , R 2 and R 4 are —OH or an ester and R 3 is —OH, an ester or —Br.

11. The compound of claim 10 wherein R 5 is —CH 3 .

12. The compound of claim 11 wherein R 6 is —H or —CH 3 .

13. The compound of claim 10 wherein the compound has the structure

14. The compound of claim 10 wherein the compound has the structure

15. The compound of claim 13 wherein the compound has the structure

16. The compound of claim 15 wherein R 1 , R 2 and R 4 are —OH and R 3 is —OH or Br.

17. The compound of claim 16 wherein the compound has the structure

18. The formulation of claim 6 wherein the compound has the structure

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2021
From: NEURMEDIX, INC.
To: NEURMEDIX, LLC
Reel/Frame 057116/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2021
From: NEURMEDIX, LLC
To: NEURMEDIX, INC.
Reel/Frame 057116/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2021
From: NEURMEDIX, INC.
To: BIOVIE INC.
Reel/Frame 057116/0451 →
CHANGE OF NAME Recorded Nov 2, 2012
From: HARBOR BIOSCIENCES, INC.
To: HARBOR DIVERSIFIED, INC.
Reel/Frame 029227/0929 →
CHANGE OF NAME Recorded Mar 11, 2010
From: HOLLIS-EDEN PHARMACEUTICALS, INC.
To: HARBOR BIOSCIENCES, INC.
Reel/Frame 024066/0325 →
Continuity (21)
Continuation 10877911 · Jun 24, 2004
Continuation 09820483 · Mar 29, 2001
Continuation In Part 09449184 · Nov 24, 1999
Continuation In Part 09414905 · Oct 8, 1999
Continuation In Part 09449004 · Nov 24, 1999
Continuation In Part 09535675 · Mar 23, 2000
Continuation In Part 09449042 · Nov 24, 1999
Continuation In Part 09675470 · Sep 28, 2000
Continuation In Part 09586673 · Jun 1, 2000
Continuation In Part 09586672 · Jun 1, 2000
Continuation In Part 09461026 · Dec 15, 1999
Provisional Application 60109924 · Nov 24, 1998
Provisional Application 60140028 · Jun 16, 1999
Provisional Application 60109923 · Nov 24, 1998
Provisional Application 60126056 · Mar 23, 1999
Provisional Application 60110127 · Nov 27, 1998
Provisional Application 60161453 · Oct 25, 1999
Provisional Application 60145823 · Jul 27, 1999
Provisional Application 60137745 · Jun 3, 1999
Provisional Application 60112206 · Dec 15, 1998
Related Publication 20110009372A1 · Jan 13, 2011